DANCR

ncRNA information

ncRNA name

DANCR

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

mTOR/HIF-1Ī±

Cancer information

Cancer name

Gastric Cancer

Cancer site

Stomach

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

62

Male patients

32

Female patients

30

Age range and number

Not available

Research information

PMID

Description

Upregulation of DANCR can accelerate the MDR development of GC, which may become a potential target for treating GC with MDR.

Tissue resource

DDP-sensitive gastric cancer tissues and cases of cisplatin-resistant gastric cancer tissues

gastric cancer cell lines SGC7901

gastric cancer cell lines BGC823

Experiment

qRT-PCR,Western blot


Institute

the Yantai Yuhuangding Hospital

the Cell Bank, Chinese Academy of Sciences

Country

China

Continent

Asia